India Drug Delivery Devices Market Size, Share, and Competitive Analysis by 2029 – A Comprehensive Study from TechSci Research


The India Drug Delivery Devices Market is witnessing remarkable growth, fueled by the rising prevalence of chronic diseases, an aging population, and technological advancements in the field of drug delivery. According to a report by TechSci Research, titled “India Drug Delivery Devices Market – Industry Size, Share, Trends, Competition Forecast & Opportunities, 2029F,” the market stood at USD 45.70 Billion in 2023 and is anticipated to grow with an impressive CAGR of 6.11% during the forecast period of 2025-2029.

Driving Forces behind Market Growth

Rising Prevalence of Chronic Diseases and Aging Population

A significant driving force behind the growth of the Drug Delivery Devices market in India is the rising prevalence of chronic diseases such as diabetes, cardiovascular disorders, and cancer. These chronic conditions necessitate effective drug delivery systems to manage and treat them. Additionally, the aging population in India and the associated increase in age-related ailments contribute to this trend, further fueling the demand for innovative drug delivery devices.


Browse over XX market data Figures spread through XX Pages and an in-depth TOC on “India Drug Delivery Devices Market” –


Technological Advancements and Healthcare Infrastructure Expansion

Advancements in technology are leading to the development of innovative and more efficient drug delivery devices, stimulating market growth. The expansion of healthcare infrastructure and increased healthcare spending in India provide a conducive environment for the development and adoption of these advanced devices.

Growing Population and Healthcare Needs

India, with its second-largest population in the world, is witnessing a surge in demand for better healthcare facilities. This growing population has led to an increased need for innovative drug delivery devices, which are flourishing in the Indian market. The rising prevalence of chronic diseases, such as diabetes, has put a significant burden on the Indian population, necessitating more advanced and efficient delivery systems to effectively manage and treat these conditions.

Strategic Initiatives by Key Players

The demand for drug delivery devices has been positively influenced by the increasing adoption of innovative strategies by key market players. These players are actively focusing on developing devices with advanced features, such as digital capabilities and the next-generation of injectable devices. For example, Berry Global Group, in August 2021, announced plans to construct a second manufacturing plant and a worldwide center of excellence for healthcare in Bangalore, India. This strategic initiative aims to strengthen Berry’s position in the market for inhalation devices and injectable devices, further driving the growth of the drug delivery device market in India.

Challenges and Opportunities

While the growth prospects of the Drug Delivery Devices market in India are promising, there are challenges that need to be addressed. The risk of infections and side effects associated with these devices poses a concern for both patients and healthcare providers. Additionally, stringent regulatory guidelines for the approval of drug delivery devices can hinder market growth. It is crucial for manufacturers and regulatory authorities to collaborate and ensure the safety and efficacy of these devices to overcome these challenges.

Despite these challenges, the market for drug delivery devices in India is poised for significant expansion, driven by the increasing healthcare needs of the population and advancements in technology. The potential to improve patient outcomes and enhance the overall healthcare landscape in India makes this an exciting and promising market for drug delivery device manufacturers and stakeholders.

Market Segmentation

The India Drug Delivery Devices Market is segmented into devices, route of administration, application, end-user, regional distribution, and company.

Route of Administration Segmentation

Based on the route of administration, Topical drug delivery devices are projected to experience substantial growth in the future, primarily due to the numerous benefits associated with this route of administration, including ease of use, painless and noninvasive delivery, convenience, and superior spreadability.

The growth of this segment is also driven by the increasing prevalence of skin diseases and improved patient compliance. For instance, studies have reported a prevalence of 2.7% among 6–7-year-olds and 3.6% among 13–14-year-olds for atopic dermatitis in India, and 88.74% of patients reported a progressive course of psoriasis.

Furthermore, advancements in topical drug delivery systems, such as the introduction of novel time-controlled drug delivery mechanisms leveraging modern mathematical models, sophisticated instrumentation, and computational power, have revolutionized the formulation process. These advancements have led to the widespread adoption of topical drug delivery systems in India.

Regional Segmentation

Based on region, the western region of India holds a dominant position in the country’s Drug Delivery Devices Market, owing to several factors:

  1. Presence of Major Pharmaceutical Companies: The region is home to several major pharmaceutical companies that benefit from robust infrastructure and a highly skilled labor force.
  2. Favorable Government Policies: The western region enjoys strong governmental support through favorable regulatory policies and incentives for research and development within the pharmaceutical sector.
  3. Populous Urban Centers: The region encompasses populous cities like Mumbai and Pune, providing a substantial consumer base that drives demand for innovative drug delivery devices.
  4. Affluent Demographics and Health Awareness: The region’s affluent demographics and growing health awareness among its residents further contribute to the market’s continual growth.

Competitive Analysis

The India Drug Delivery Devices Market is highly competitive, with both domestic and international players vying for market share. Companies employ various strategies to gain a competitive edge, including:

  1. Product Innovation: Continuous investment in research and development to introduce innovative drug delivery devices that address unmet clinical needs and improve patient outcomes.
  2. Strategic Partnerships and Collaborations: Collaborations with research institutions, universities, and technology companies enable companies to leverage expertise, resources, and market reach.
  3. Geographic Expansion: Companies aim to expand their global footprint by entering new markets, adapting their offerings to local healthcare needs, and establishing strategic partnerships with regional players.
  4. Mergers and Acquisitions: Mergers and acquisitions are pursued to consolidate market positions, expand product portfolios, and gain access to new technologies and markets.
  5. Regulatory Compliance and Quality Standards: Adhering to stringent regulatory requirements, obtaining necessary approvals, and maintaining high-quality standards are crucial for companies operating in the India Drug Delivery Devices Market.

Benefits of the Research Report

The research report on the India Drug Delivery Devices Market provides valuable insights and benefits to stakeholders:

  • Market Size and Growth Projections: The report offers a comprehensive analysis of the current market size and future growth projections, enabling companies to make informed business decisions and strategic plans.
  • Competitive Landscape Analysis: An in-depth competitive analysis helps companies understand the strengths and weaknesses of their competitors, identify potential threats and opportunities, and develop effective strategies to gain a competitive edge.
  • Segment Analysis: By providing detailed segment analysis based on devices, route of administration, application, end-user, regional distribution, and company, the report enables companies to identify high-growth segments and tailor their offerings accordingly.
  • Regulatory and Policy Insights: The report provides insights into the regulatory landscape and policies governing the drug delivery devices market in India, allowing companies to navigate regulatory requirements and ensure compliance.
  • Trends and Drivers: Understanding the key trends, drivers, and challenges shaping the market helps companies anticipate and adapt to market changes, mitigate risks, and capitalize on emerging opportunities.
  • Investment Opportunities: The report serves as a valuable resource for investors, highlighting lucrative investment opportunities and potential areas for growth in the India Drug Delivery Devices Market.

The India Drug Delivery Devices Market presents a unique opportunity for companies and stakeholders to revolutionize healthcare delivery in the country. With the rising prevalence of chronic diseases, an aging population, and technological advancements, the demand for innovative drug delivery devices is poised for significant growth. By addressing the challenges and leveraging the market’s potential, companies can contribute to improving patient outcomes and enhancing the overall healthcare landscape in India.

Major companies operating in India Drug Delivery Devices Market are:

  • Pfizer Ltd.
  • Novartis India Ltd.
  • GlaxoSmithKline Pharmaceuticals Ltd.
  • India Medtronic Private Ltd.
  • Cardinal Health India Pvt Ltd.
  • B. Braun Medical (India) Pvt. Ltd.
  • Sun Pharmaceutical Industries Ltd.
  • 3M India Ltd.
  • Cipla Ltd.
  • Bayer Pharmaceuticals Pvt. Ltd.


Download Free Sample Report –

Customers can also request for 10% free customization on this report


“The India drug delivery devices market is expected to witness significant growth during the forecast period. This growth can be attributed to the increasing demand for drug delivery devices and the rising awareness about health among the population. The market is also driven by the introduction of technological advancements and novel products in the field of drug delivery. These smart drug delivery devices are designed to effectively manage various diseases. Furthermore, the rapid development in the health sector has led to an increased demand for drug delivery devices in India. With the changing lifestyle and the rise in the number of fatal diseases, there is a growing need for efficient drug delivery systems. These devices play a crucial role in ensuring the accurate and timely administration of medications, thus improving patient outcomes. The India drug delivery devices market is poised for significant growth in the coming years. The advancements in technology and the focus on improving healthcare outcomes are driving the demand for innovative drug delivery devices in the country.,” said Mr. Karan Chechi, Research Director with TechSci Research, a research-based management consulting firm.

“India Drug Delivery Devices Market By Devices (Syringe, Inhaler, Nebulizer, Transdermal Patch), By Route of Administration (Oral Drug Delivery, Injectable Drug Delivery, Topical Drug Delivery, Others), By Application (Cancer, Respiratory Diseases, Diabetes, Cardiovascular Diseases, Others), By End User (Hospitals, Diagnostic Centres, Ambulatory Surgery Centres, Others), By Region, Competition, Forecast & Opportunities, 2019-2019F”, has evaluated the future growth potential of India Drug Delivery Devices Market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in India Drug Delivery Devices Market.

Download Free Sample Report –


Contact Techsci Research

US –

Techsci Research LLC

420 Lexington Avenue, Suite 300,

New York, United States- 10170

Tel: +13322586602




About Author